Have to say that the trials did demonstrate some good results - unfortunately, not definitive enough to get BP support.
Would have preferred a longer trial that could have demonstrated affects over a long period but that was not done.
BIT will need a third party to either commercialise BIT225 for other end users or to get funding for a phase 3 trial.
Given the lack of interest so far, I can't see that happening. Maybe only 12 months of life left for BIT in that case.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.318M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.3¢ | 0.2¢ | $5.225K | 2.145M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 30632029 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 15607062 | 19 |
View Market Depth
| Last trade - 10.06am 28/07/2025 (20 minute delay) ? |
| BIT (ASX) Chart |